Not recruitingISRCTN15969819

Continuing versus gradually stopping antidepressants to study depression relapse

About this title

A Phase IV double blind multi-site, individually randomised parallel group controlled trial investigating the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in patients in primary care who are taking long term maintenance antidepressants but now feel well enough to consider stopping medication

Read the official source — ISRCTN15969819

Research studyAges 18–74United Kingdom

The study in practice

Understand this study

Who could participate?

This study is for people with depression. Listed age limits: 18 years to 74 years. Other eligibility criteria apply.

Listed locations: United Kingdom

Get this study by email

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateNot clearly listed

Recruitment status: Not recruiting
Enrollment listed in the registry: Not clearly listed
Sponsor: PRIMENT CTU, University College London
Sponsor type: University
Study type: Other
Intervention type: Other / unclear
Locations: United Kingdom
Age range: From 18 Years to 74 Years
Official registry ID: ISRCTN15969819
Official title: Show the full official title
Antidepressants to prevent relapse in depression

Recruitment & locations

Not recruiting

United Kingdom

Interested in joining this study?

FAQ

Questions about this study

Who is behind this study?

The study sponsor is PRIMENT CTU, University College London, a university.

Who can participate?

This study is for people with depression. Listed age limits: 18 years to 74 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as not recruiting.

Want to explore more studies?

Explore studies